Literature DB >> 21307838

Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function.

Zoltán H Endre1, John W Pickering, Robert J Walker, Prasad Devarajan, Charles L Edelstein, Joseph V Bonventre, Christopher M Frampton, Michael R Bennett, Qing Ma, Venkata S Sabbisetti, Vishal S Vaidya, Angela M Walcher, Geoffrey M Shaw, Seton J Henderson, Maryam Nejat, John B W Schollum, Peter M George.   

Abstract

To better understand the diagnostic and predictive performance of urinary biomarkers of kidney injury, we evaluated γ-glutamyltranspeptidase (GGT), alkaline phosphatase (AP), neutrophil-gelatinase-associated lipocalin (NGAL), cystatin C (CysC), kidney injury molecule-1 (KIM-1), and interleukin-18 (IL-18) in a prospective observational study of 529 patients in 2 general intensive care units (ICUs). Comparisons were made using the area under the receiver operator characteristic curve (AUC) for diagnosis or prediction of acute kidney injury (AKI), dialysis, or death, and reassessed after patient stratification by baseline renal function (estimated glomerular filtration rate, eGFR) and time after renal insult. On ICU entry, no biomarker had an AUC above 0.7 in the diagnosis or prediction of AKI. Several biomarkers (NGAL, CysC, and IL-18) predicted dialysis (AUC over 0.7), and all except KIM-1 predicted death at 7 days (AUC between 0.61 and 0.69). Performance was improved by stratification for eGFR or time or both. With eGFR <60 ml/min, CysC and KIM-1 had AUCs of 0.69 and 0.73, respectively, within 6 h of injury, and between 12 and 36 h, CysC (0.88), NGAL (0.85), and IL-18 (0.94) had utility. With eGFR >60 ml/min, GGT (0.73), CysC (0.68), and NGAL (0.68) had the highest AUCs within 6 h of injury, and between 6 and 12 h, all AUCs except AP were between 0.68 and 0.78. Beyond 12 h, NGAL (0.71) and KIM-1 (0.66) performed best. Thus, the duration of injury and baseline renal function should be considered in evaluating biomarker performance to diagnose AKI.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21307838      PMCID: PMC3884688          DOI: 10.1038/ki.2010.555

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  37 in total

1.  Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery.

Authors:  Jaya Mishra; Catherine Dent; Ridwan Tarabishi; Mark M Mitsnefes; Qing Ma; Caitlin Kelly; Stacey M Ruff; Kamyar Zahedi; Mingyuan Shao; Judy Bean; Kiyoshi Mori; Jonathan Barasch; Prasad Devarajan
Journal:  Lancet       Date:  2005 Apr 2-8       Impact factor: 79.321

2.  Creatinine as the gold standard for kidney injury biomarker studies?

Authors:  Sushrut S Waikar; Rebecca A Betensky; Joseph V Bonventre
Journal:  Nephrol Dial Transplant       Date:  2009-09-07       Impact factor: 5.992

3.  Elevated urinary IL-18 levels at the time of ICU admission predict adverse clinical outcomes.

Authors:  Edward D Siew; T Alp Ikizler; Tebeb Gebretsadik; Ayumi Shintani; Nancy Wickersham; Frederick Bossert; Josh F Peterson; Chirag R Parikh; Addison K May; Lorraine B Ware
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-17       Impact factor: 8.237

4.  Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery.

Authors:  Won K Han; Gebhard Wagener; Yanqing Zhu; Shuang Wang; H Thomas Lee
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-30       Impact factor: 8.237

Review 5.  Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review.

Authors:  S G Coca; R Yalavarthy; J Concato; C R Parikh
Journal:  Kidney Int       Date:  2007-12-19       Impact factor: 10.612

6.  Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury.

Authors:  Won K Han; Veronique Bailly; Rekha Abichandani; Ravi Thadhani; Joseph V Bonventre
Journal:  Kidney Int       Date:  2002-07       Impact factor: 10.612

7.  Commonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury.

Authors:  Edward D Siew; Michael E Matheny; T Alp Ikizler; Julie B Lewis; Randolph A Miller; Lemuel R Waitman; Alan S Go; Chirag R Parikh; Josh F Peterson
Journal:  Kidney Int       Date:  2009-12-30       Impact factor: 10.612

8.  Evaluation of trial outcomes in acute kidney injury by creatinine modeling.

Authors:  John W Pickering; Christopher M Frampton; Zoltán H Endre
Journal:  Clin J Am Soc Nephrol       Date:  2009-09-03       Impact factor: 8.237

9.  Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial).

Authors:  Zoltán H Endre; Robert J Walker; John W Pickering; Geoffrey M Shaw; Christopher M Frampton; Seton J Henderson; Robyn Hutchison; Jan E Mehrtens; Jillian M Robinson; John B W Schollum; Justin Westhuyzen; Leo A Celi; Robert J McGinley; Isaac J Campbell; Peter M George
Journal:  Kidney Int       Date:  2010-02-17       Impact factor: 10.612

10.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.

Authors:  Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more
  102 in total

1.  Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats.

Authors:  Nathaniel J Rhodes; Walter C Prozialeck; Thomas P Lodise; Natarajan Venkatesan; J Nicholas O'Donnell; Gwendolyn Pais; Cameron Cluff; Peter C Lamar; Michael N Neely; Anil Gulati; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

2.  Development of a Multicenter Ward-Based AKI Prediction Model.

Authors:  Jay L Koyner; Richa Adhikari; Dana P Edelson; Matthew M Churpek
Journal:  Clin J Am Soc Nephrol       Date:  2016-09-15       Impact factor: 8.237

3.  Biomarker Enhanced Risk Prediction for Adverse Outcomes in Critically Ill Patients Receiving RRT.

Authors:  Francis Pike; Raghavan Murugan; Christopher Keener; Paul M Palevsky; Anitha Vijayan; Mark Unruh; Kevin Finkel; Xiaoyan Wen; John A Kellum
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-05       Impact factor: 8.237

Review 4.  Biomarkers for the Early Detection and Prognosis of Acute Kidney Injury.

Authors:  Rakesh Malhotra; Edward D Siew
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-08       Impact factor: 8.237

5.  Have biomarkers failed in acute kidney injury? No.

Authors:  Blaithin A McMahon; Jay L Koyner
Journal:  Intensive Care Med       Date:  2017-04-24       Impact factor: 17.440

Review 6.  Perspective on Clinical Application of Biomarkers in AKI.

Authors:  Chirag R Parikh; Sherry G Mansour
Journal:  J Am Soc Nephrol       Date:  2017-02-20       Impact factor: 10.121

Review 7.  Recent advances in acute kidney injury epidemiology.

Authors:  Edward D Siew; Serpil M Deger
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-05       Impact factor: 2.894

8.  A porphyrin-PEG polymer with rapid renal clearance.

Authors:  Haoyuan Huang; Reinier Hernandez; Jumin Geng; Haotian Sun; Wentao Song; Feng Chen; Stephen A Graves; Robert J Nickles; Chong Cheng; Weibo Cai; Jonathan F Lovell
Journal:  Biomaterials       Date:  2015-10-21       Impact factor: 12.479

Review 9.  Biomarkers of AKI: a review of mechanistic relevance and potential therapeutic implications.

Authors:  Joseph L Alge; John M Arthur
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-04       Impact factor: 8.237

10.  Urine Biomarkers and Perioperative Acute Kidney Injury: The Impact of Preoperative Estimated GFR.

Authors:  Jay L Koyner; Steven G Coca; Heather Thiessen-Philbrook; Uptal D Patel; Michael G Shlipak; Amit X Garg; Chirag R Parikh
Journal:  Am J Kidney Dis       Date:  2015-09-16       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.